Rankings
▼
Calendar
KNSA Q1 2017 Earnings — Kiniksa Pharmaceuticals, Ltd. Revenue & Financial Results | Market Cap Arena
KNSA
Kiniksa Pharmaceuticals, Ltd.
$3B
Q1 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$5M
Net Income
-$5M
EPS (Diluted)
$-0.15
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$114,000
Balance Sheet
Total Assets
$0
Total Liabilities
$0
Stockholders' Equity
$54M
Cash & Equivalents
-$56M
← FY 2017
All Quarters
Q2 2017 →
